CTMX   $1.16  0.87% Market Open

CytomX Therapeutics Inc
Total Cash 137.18M
totalCashPerShare 1.756
EBITDA 7.62M
Total Debt 11.75M
quickRatio 0.98
currentRatio 1.002
Total Revenue 119.57M
debtToEquity
Revenue/Share 1.452
ROA 0.01941
ROE
grossProfits
freeCashflow 14.55M
operatingCashflow -85.80M
earningsGrowth
revenueGrowth 0.016
grossMargins 1.0
ebitdaMargins 0.06371
operatingMargins -0.33653
profitMargins 0.09272
enterpriseValue -33.26M
forwardPE -1.9098359
floatShares 66.34M
sharesOutstanding 78.12M
sharesShort 6.25M
sharesShortPriorMonth 7.15M
dateShortInterest
sharesPercentSharesOut 0.08%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.73%
Short Ratio help_outline 7.73%
shortPercentOfFloat 0.08%
impliedSharesOutstanding
bookValue -0.4
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon 11.09M
trailingEps 0.15%
forwardEps -0.61%
enterpriseToEbitda -4.37
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.17 3Q 2024
institutionsCount 88
lastUpdated Oct. 21, 2024, 8:57 p.m.